TY - JOUR
T1 - Synthesis of thymidine phosphorylase inhibitor based on quinoxaline derivatives and their molecular docking study
AU - Almandil, Noor Barak
AU - Taha, Muhammad
AU - Farooq, Rai Khalid
AU - Alhibshi, Amani
AU - Ibrahim, Mohamed
AU - Anouar, El Hassane
AU - Gollapalli, Mohammed
AU - Rahim, Fazal
AU - Nawaz, Muhammad
AU - Shah, Syed Adnan Ali
AU - Ahmed, Qamar Uddin
AU - Zakaria, Zainul Amiruddin
N1 - Publisher Copyright:
© 2019 by the authors.
PY - 2019
Y1 - 2019
N2 - We have synthesized quinoxaline analogs (1–25), characterized by 1H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 µM). The most potent compound among the series is analog 25 with IC50 value 3.20 ± 0.10 µM. Sixteen analogs 1, 2, 3, 4, 5, 6, 7, 12, 13, 14, 15, 16, 17, 18, 21 and 24 showed outstanding inhibition which is many folds better than the standard 7-Deazaxanthine. Two analogs 8 and 9 showed moderate inhibition. A structure-activity relationship has been established mainly based upon the substitution pattern on the phenyl ring. The binding interactions of the active compounds were confirmed through molecular docking studies.
AB - We have synthesized quinoxaline analogs (1–25), characterized by 1H-NMR and HREI-MS and evaluated for thymidine phosphorylase inhibition. Among the series, nineteen analogs showed better inhibition when compared with the standard inhibitor 7-Deazaxanthine (IC50 = 38.68 ± 4.42 µM). The most potent compound among the series is analog 25 with IC50 value 3.20 ± 0.10 µM. Sixteen analogs 1, 2, 3, 4, 5, 6, 7, 12, 13, 14, 15, 16, 17, 18, 21 and 24 showed outstanding inhibition which is many folds better than the standard 7-Deazaxanthine. Two analogs 8 and 9 showed moderate inhibition. A structure-activity relationship has been established mainly based upon the substitution pattern on the phenyl ring. The binding interactions of the active compounds were confirmed through molecular docking studies.
KW - Molecular docking
KW - Quinoxaline analogs
KW - Synthesis
KW - Thymidine phosphorylase inhibition
UR - http://www.scopus.com/inward/record.url?scp=85062955700&partnerID=8YFLogxK
U2 - 10.3390/molecules24061002
DO - 10.3390/molecules24061002
M3 - Article
C2 - 30871147
AN - SCOPUS:85062955700
SN - 1420-3049
VL - 24
JO - Molecules
JF - Molecules
IS - 6
M1 - 1002
ER -